| 
The Fanconi Cancer Foundation (FCF) and the American Cancer Society (ACS) have partnered to launch the Fanconi Cancer Foundation Discovery Boost Grant, funding translational research on cancers associated with Fanconi anemia (FA). What we’re looking for:
Proposals must be translational in nature and directly applicable to FA-associated cancers, especially those linked to defects in the FA/BRCA DNA repair pathway. We encourage applications from FA experts and from investigators in related cancer biology fields who are pivoting toward FA-relevant studies. Areas of interest include: - Early detection technologies and biomarkers for FA-related squamous cell carcinomas
- Mechanisms or interventions to prevent FA-related tumors
- Therapeutic strategies tailored to FA’s sensitivity to DNA-damaging agents
- Novel models to study FA tumorigenesis and treatment response
- High-throughput or systems biology approaches to identify FA-specific cancer vulnerabilities
Preference will be given to proposals with a clear translational path for detecting, preventing, or treating cancer in people with FA, including collaborations with clinicians, diagnostic developers, or pharmaceutical partners. Funding details: - Up to $135,000 per year for two years (plus 10% indirect costs)
- Maximum $297,000 total for a two-year project period
Apply now:
Applications for the Discovery Boost Grant are open and due December 1, 2025. Learn more and Apply here. | 